Literature DB >> 30535624

Adrenal myelolipoma in association with congenital adrenal hyperplasia.

Hee Jin Kim1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30535624     DOI： 10.1007/s12020-018-1827-6

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  5 in total

1.  CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY PRESENTING AS ADRENAL INCIDENTALOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS.

Authors:  Henrik Falhammar; David J Torpy
Journal:  Endocr Pract       Date:  2016-02-26       Impact factor: 3.443

2.  The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas.

Authors:  Martha A Zeiger; Geoffrey B Thompson; Quan-Yang Duh; Amir H Hamrahian; Peter Angelos; Dina Elaraj; Elliott Fishman; Julia Kharlip
Journal:  Endocr Pract       Date:  2009 Jul-Aug       Impact factor: 3.443

Review 3.  Adrenal myelolipoma: a comprehensive review.

Authors:  Ábel Decmann; Pál Perge; Miklós Tóth; Peter Igaz
Journal:  Endocrine       Date:  2017-11-21       Impact factor: 3.633

Review 4.  AME position statement on adrenal incidentaloma.

Authors:  M Terzolo; A Stigliano; I Chiodini; P Loli; L Furlani; G Arnaldi; G Reimondo; A Pia; V Toscano; M Zini; G Borretta; E Papini; P Garofalo; B Allolio; B Dupas; F Mantero; A Tabarin
Journal:  Eur J Endocrinol       Date:  2011-04-06       Impact factor: 6.664

5.  Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.

Authors:  Martin Fassnacht; Wiebke Arlt; Irina Bancos; Henning Dralle; John Newell-Price; Anju Sahdev; Antoine Tabarin; Massimo Terzolo; Stylianos Tsagarakis; Olaf M Dekkers
Journal:  Eur J Endocrinol       Date:  2016-08       Impact factor: 6.664
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.